Lucentis Prefilled Syringe approved by FDA

Doctors will now have an alternative when it comes to administering Lucentis injections for patients with advanced macular degeneration or diabetic retinopathy. The FDA recently announced its approval of .5 mg pre-filled syringes of Luncentis for the treatment of patients with wet age-related macular degeneration, macular edema and retinal vein occlusion. Currently, physicians have several steps to go through before administering an injection of Lucentis. The vial must be disinfected, a filter needle must be attached, the medicine must be withdrawn using the needle and then the filter needle must then be removed from the syringe and replaced with an injection needle. The new pre-filled syringe allows the doctor to attach the injection need to the syringe and simply adjust the dosage before the injection is administered. The new pre-filled syringes will be available in early 2017.*